Mobidiag

Mobidiag is a biotechnology company focused on the development and commercialization of molecular diagnostic solutions for clinical laboratories to detect infectious diseases and antibiotic resistance. The goal is to enable rapid, accurate, and convenient in vitro diagnostics to improve the quality and efficiency of healthcare systems, help prevent the spread of antibiotic resistance, and provide new opportunities for routine diagnostics. Mobidiag leverages existing technologies and expertise to quickly develop and deliver two molecular diagnostic tests for coronaviruses. Thus, this global solution offers clinicians a complete solution tailored to the needs and capabilities of their own laboratories.